Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B8WU
|
|||
| Former ID |
DIB016397
|
|||
| Drug Name |
JTZ-951
|
|||
| Indication | Anaemia [ICD-11: 3A90; ICD-10: D64.8] | Phase 3 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H16N4O4
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CCC2=CC(=O)C(=C3N2NC=N3)C(=O)NCC(=O)O
|
|||
| InChI |
1S/C17H16N4O4/c22-13-8-12(7-6-11-4-2-1-3-5-11)21-16(19-10-20-21)15(13)17(25)18-9-14(23)24/h1-5,8,10H,6-7,9H2,(H,18,25)(H,19,20)(H,23,24)
|
|||
| InChIKey |
FJYRBJKWDXVHHO-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1262132-81-9
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | HIF-prolyl hydroxylase (HPH) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04027517) A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.. U.S. National Institutes of Health. | |||
| REF 2 | DOI: 10.1038/nrneph.2015.82 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.